F&FFinancial Insights

Financial Metrics

PACS PACS Group, Inc.
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 708442000.0 USD 10-Q 2024-05-13
Quarterly 2023-06-30 760664000.0 +7.4% USD 10-Q 2024-08-12
Quarterly 2023-09-30 789186000.0 +3.7% USD 10-Q 2025-11-19
Quarterly 2024-03-31 919836000.0 +16.6% USD 10-Q 2025-11-19
Quarterly 2024-06-30 935705000.0 +1.7% USD 10-Q 2025-11-19
Quarterly 2024-09-30 1026305000.0 +9.7% USD 10-Q 2025-11-19
Quarterly 2025-03-31 1277150000.0 +24.4% USD 10-Q 2025-11-19
Quarterly 2025-06-30 1309236000.0 +2.5% USD 10-Q 2025-11-19
Quarterly 2025-09-30 1344567000.0 +2.7% USD 10-Q 2025-11-19
Annual 2022-12-31 2421994000.0 USD 10-K 2025-11-19
Annual 2023-12-31 3111492000.0 +28.5% USD 10-K 2026-02-27
Annual 2024-12-31 4089734000.0 +31.4% USD 10-K 2026-02-27
Annual 2025-12-31 5288932000.0 +29.3% USD 10-K 2026-02-27

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Operating Income

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 59295000.0 USD 10-Q 2024-05-13
Quarterly 2023-06-30 49539000.0 -16.5% USD 10-Q 2024-08-12
Quarterly 2023-09-30 36402000.0 -26.5% USD 10-Q 2025-11-19
Quarterly 2024-03-31 65309000.0 +79.4% USD 10-Q 2025-11-19
Quarterly 2024-06-30 -37179000.0 -156.9% USD 10-Q 2025-11-19
Quarterly 2024-09-30 22964000.0 +161.8% USD 10-Q 2025-11-19
Quarterly 2025-03-31 48140000.0 +109.6% USD 10-Q 2025-11-19
Quarterly 2025-06-30 80499000.0 +67.2% USD 10-Q 2025-11-19
Quarterly 2025-09-30 86269000.0 +7.2% USD 10-Q 2025-11-19
Annual 2022-12-31 229360000.0 USD 10-K 2025-11-19
Annual 2023-12-31 207772000.0 -9.4% USD 10-K 2026-02-27
Annual 2024-12-31 123073000.0 -40.8% USD 10-K 2026-02-27
Annual 2025-12-31 309595000.0 +151.6% USD 10-K 2026-02-27

Net Income

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 37597000.0 USD 10-Q 2025-11-19
Quarterly 2023-06-30 21218000.0 -43.6% USD 10-Q 2025-11-19
Quarterly 2023-09-30 19927000.0 -6.1% USD 10-Q 2025-11-19
Quarterly 2024-03-31 34817000.0 +74.7% USD 10-Q 2025-11-19
Quarterly 2024-06-30 -31878000.0 -191.6% USD 10-Q 2025-11-19
Quarterly 2024-09-30 16210000.0 +150.9% USD 10-Q 2025-11-19
Quarterly 2025-03-31 28472000.0 +75.6% USD 10-Q 2025-11-19
Quarterly 2025-06-30 50963000.0 +79.0% USD 10-Q 2025-11-19
Quarterly 2025-09-30 52330000.0 +2.7% USD 10-Q 2025-11-19
Annual 2022-12-31 150496000.0 USD 10-K 2025-11-19
Annual 2023-12-31 112882000.0 -25.0% USD 10-K 2026-02-27
Annual 2024-12-31 55344000.0 -51.0% USD 10-K 2026-02-27
Annual 2025-12-31 191461000.0 +245.9% USD 10-K 2026-02-27

EPS Basic

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 0.29 USD/shares 10-Q 2024-05-13
Quarterly 2023-06-30 0.16 -44.8% USD/shares 10-Q 2024-08-12
Quarterly 2023-09-30 0.15 -6.3% USD/shares 10-Q 2025-11-19
Quarterly 2024-03-31 0.27 +80.0% USD/shares 10-Q 2025-11-19
Quarterly 2024-06-30 -0.21 -177.8% USD/shares 10-Q 2025-11-19
Quarterly 2024-09-30 0.1 +147.6% USD/shares 10-Q 2025-11-19
Quarterly 2025-03-31 0.18 +80.0% USD/shares 10-Q 2025-11-19
Quarterly 2025-06-30 0.33 +83.3% USD/shares 10-Q 2025-11-19
Quarterly 2025-09-30 0.33 +0.0% USD/shares 10-Q 2025-11-19
Annual 2022-12-31 1.17 USD/shares 10-K 2025-11-19
Annual 2023-12-31 0.88 -24.8% USD/shares 10-K 2026-02-27
Annual 2024-12-31 0.38 -56.8% USD/shares 10-K 2026-02-27
Annual 2025-12-31 1.23 +223.7% USD/shares 10-K 2026-02-27

EPS Diluted

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 0.29 USD/shares 10-Q 2024-05-13
Quarterly 2023-06-30 0.16 -44.8% USD/shares 10-Q 2024-08-12
Quarterly 2023-09-30 0.15 -6.3% USD/shares 10-Q 2025-11-19
Quarterly 2024-03-31 0.27 +80.0% USD/shares 10-Q 2025-11-19
Quarterly 2024-06-30 -0.21 -177.8% USD/shares 10-Q 2025-11-19
Quarterly 2024-09-30 0.1 +147.6% USD/shares 10-Q 2025-11-19
Quarterly 2025-03-31 0.17 +70.0% USD/shares 10-Q 2025-11-19
Quarterly 2025-06-30 0.31 +82.4% USD/shares 10-Q 2025-11-19
Quarterly 2025-09-30 0.32 +3.2% USD/shares 10-Q 2025-11-19
Annual 2022-12-31 1.17 USD/shares 10-K 2025-11-19
Annual 2023-12-31 0.88 -24.8% USD/shares 10-K 2026-02-27
Annual 2024-12-31 0.38 -56.8% USD/shares 10-K 2026-02-27
Annual 2025-12-31 1.22 +221.1% USD/shares 10-K 2026-02-27

8-K Material Event Details

20 filings · 40 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

16 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-24 Priegnitz Kelly Chief Compliance Officer Equity grant / award
A
Common Stock 8,203 $0.00 $0 38,203
2026-03-13 Jergensen Joshua President & COO Open-market sell
S
Common Stock 36,335 $34.28 $1,245,647 2,667,347
2026-03-05 Hancock Mark Co Fndr; Int CFO; Exec V Chair Equity grant / award
G
Common Stock 300,000 $0.00 $0 54,504,443
2026-03-04 Conway Patrick Hugh Dir Equity grant / award
A
Common Stock 3,497 $0.00 $0 3,497
2026-03-03 Priegnitz Kelly Chief Compliance Officer Equity grant / award
A
Common Stock 30,000 $0.00 $0 30,000
2026-01-15 Lewis Michelle Renee Chief Accounting Officer Other disposed transaction
F
Common Stock 3,348 $39.49 $132,213 374,870
2025-12-19 LEAVITT TAYLOR S. Dir Equity grant / award
A
Common Stock 4,399 $0.00 $0 10,837
2025-12-17 Lewis Michelle Renee Chief Accounting Officer Equity grant / award
A
Common Stock 19,127 $0.00 $0 378,218
2025-12-17 Lewis Michelle Renee Chief Accounting Officer Equity grant / award
A
Common Stock 32,500 $0.00 $0 359,091
2025-11-24 Dilsaver Evelyn S Dir Open-market buy
P
Common Stock 16,724 $29.90 $499,997 22,739
2025-04-15 Lewis Michelle Renee Chief Accounting Officer Other disposed transaction
F
Common Stock 16,777 $9.35 $156,865 326,591
2024-09-09 Hancock Mark Co-Founder & Exec. Vice Chair. Open-market sell
S
Common Stock 8,128,352 $36.25 $294,652,760 45,126,199
2024-05-09 Millard Jacqueline Dir Equity grant / award
A
Common Stock 6,438 $0.00 $0 6,871
2024-05-09 Dilsaver Evelyn S Dir Equity grant / award
A
Common Stock 5,927 $0.00 $0 5,927
2024-04-15 Murray Jason Hulse Co-Founder, CEO & Chairman Open-market sell
S
Common Stock 1,607,142 $21.00 $33,749,982 62,754,551
2024-04-11 Millard Jacqueline Dir Open-market buy
P
Common Stock 433 $23.08 $9,993 433

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
11
Material Event Filings (8-K) — 12 months
12

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.